UKBizDB.co.uk

SHANGHAI BIOPHARMALEADER CO., LIMITED

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Shanghai Biopharmaleader Co., Limited. The company was founded 10 years ago and was given the registration number 09554070. The firm's registered office is in LONDON. You can find them at 8 Standard Road, , London, . This company's SIC code is 46750 - Wholesale of chemical products.

Company Information

Name:SHANGHAI BIOPHARMALEADER CO., LIMITED
Company Number:09554070
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:21 April 2015
End of financial year:30 April 2021
Jurisdiction:England - Wales
Industry Codes:
  • 46750 - Wholesale of chemical products
  • 47749 - Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c.

Office Address & Contact

Registered Address:8 Standard Road, London, United Kingdom, NW10 6EU
Country Origin:UNITED KINGDOM
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
Rm C1705,, No.158, Zhangyang Rd.,, Shanghai,, China.,

Secretary12 July 2017Active
Rm C1705,, No.158, Zhangyang Rd.,, Shanghai,, China., 0000

Director21 April 2015Active
8 Standard Road, London, United Kingdom, NW10 6EU

Corporate Secretary21 April 2015Active

People with Significant Control

Ms Chunlei Zhang
Notified on:02 March 2017
Status:Active
Date of birth:October 1986
Nationality:Chinese
Country of residence:China.
Address:Rm C1705,, No.158, Zhangyang Rd.,, Shanghai,, China.,
Nature of control:
  • Ownership of shares 75 to 100 percent

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (2 years ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (5 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (1 year ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (7 months remaining)

Copyright © 2025. All rights reserved.